David Tuveson Archives - Cold Spring Harbor Laboratory

Newsstand Menu

Select stories by tag

Overcoming resistance in pancreatic cancer

September 9, 2019

Controlling pancreatic tumor proliferation by targeting malignancy-specific resistance pathways in response to AKT and MAPK blockade.

Of mice and model organisms

July 31, 2019

An in-depth look at how veterinarians at CSHL help take care of the various organisms that help researchers answer fundamental biological questions.

Cancer cell’s “self eating” tactic may be its weakness

July 1, 2019

Pancreatic cancer cells are eating their own mitochondria to survive and spread. New research reveals how, hinting at a possible new drug target.

Sugars that coat proteins are a possible drug target for pancreatitis

June 20, 2019

CA19-9, a complex sugar structure coating proteins, represents a possible drug target for treatment of pancreatitis and prevention of pancreatic cancer.

Special fibroblasts help pancreatic cancer cells evade immune detection

June 13, 2019

Researchers found a specific type of cancer-associated fibroblast interacts with the immune system to help pancreatic cancer cells stay under the radar.

Fighting cancer in 3D

June 7, 2019

David Tuveson, Director of the CSHL Cancer Center, shares insights about his work on organoid technology.

Yacht race raises $6,500 for cancer research

November 29, 2018

The Masthead Cove Yacht Club raised $6,500 from their annual race, which will fund cancer research.

Turning cells against pancreatic cancer

October 26, 2018

Researchers have found a way to turn cancer-supporting cells into cells that restrict the cancerous growth in the pancreas.

Nation’s cancer centers endorse HPV vaccination

June 8, 2018

Dr. Stillman and Dr. Tuveson joined with the leaders of other institutions nationwide in endorsing a statement regarding the HPV vaccine

Organoid profiling personalizes treatments for pancreatic cancer

May 31, 2018

Pancreatic organoids grown from patients' tumors make precision medicine possible

David Tuveson elected to the AACR Board of Directors

April 13, 2018

CSHL Professor David Tuveson was elected to the Board of Directors of the American Association for Cancer Research for the 2018 - 2021 term

Halfway around the world, a reunion of friends opens door to a cancer discovery

August 31, 2017

After interviewing for a position in a pancreatic cancer lab at Cold Spring Harbor Laboratory, 7,000 miles from his hometown in South Korea, Chang-il.

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017

An epigenetic factor reprograms gene enhancers, enabling cancer cells to “remember” an earlier developmental state and causing metastasis.

CSHL to lead international team developing next-generation organoid cancer research

May 11, 2017

CSHL awarded a research subcontract by Leidos Biomedical Research to lead Cancer Model Development Center for upper-gastrointestinal cancers.

Newly discovered mutations impair key cell pathways in pancreatic cancer

May 8, 2017

Researchers have found important new clues to the development of pancreatic cancer.

CSHL Story archive for Tag: David Tuveson